U.S. Cities Skeptical Of FDA Warnings Against Medicine Imports From Canadian Firm
Critics question claims by federal officials that CanaRX jeopardizes patient safety. Many U.S. companies, cities, counties and school districts rely on the firm to help employees get cheaper medicine.